|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Spruce Biosciences (NASDAQ: SPRB) through any online brokerage.
There are no as such competitors for Spruce Biosciences.
The latest price target for Spruce Biosciences (NASDAQ: SPRB) was reported by Cowen & Co. on November 23, 2021. The analyst firm set a price target for 0.00 expecting SPRB to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Spruce Biosciences (NASDAQ: SPRB) is $2.58 last updated Mon Nov 29 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Spruce Biosciences.
Spruce Biosciences’s $Q3 earnings are confirmed for after-market on November 15, 2021.
There is no upcoming split for Spruce Biosciences.
Spruce Biosciences is in the sector and industry. They are listed on the NASDAQ.